$NEOG News

Neogen Corporation 2026 Q4 - Results - Earnings Call Presentation

Neogen Corporation (NEOG) Q4 2026 Earnings Call Transcript

Neogen Sees Q1 Sales $207.000M-$209.000M vs $204.710M Est

Neogen Sees FY2027 Sales $880.000M-$885.000M vs $849.644M Est

Neogen: Still A Difficult Story

Can Neogen Corporation (NEOG) Become One of the Market’s Best Small-Cap Turnarounds?

Is Weaker Sales And Returns Reshaping The Investment Case For Neogen’s (NEOG) Valuation Assumptions?

3 Reasons NEOG is Risky and 1 Stock to Buy Instead

Neogen’s Listeria Right Now™ Test Receives AOAC® Performance Tested Methods℠ Certification

5 Must-Read Analyst Questions From Neogen’s Q1 Earnings Call

1 Unprofitable Stock on Our Watchlist and 2 Facing Challenges

Assessing Neogen (NEOG) Valuation After Earnings Beat And Higher Full Year Guidance

NEOG Q1 Deep Dive: Margin Expansion, Supplier Challenges, and Transformation Initiatives

Neogen Corp (NEOG) Q3 2026 Earnings Call Highlights: Navigating Growth and Challenges

Neogen Stock Tumbles. Why a Guidance Hike and Earnings Beat Aren’t Helping.

Neogen Corporation Q3 2026 Earnings Call Summary

Neogen (NEOG) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Neogen (NEOG) Q3 2025 Earnings Call Transcript

Neogen Q3 Earnings Call Highlights

NEOGEN CORP (NASDAQ:NEOG) Posts Q3 Beat but Cuts Outlook as Animal Safety Segment Slumps